Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CPRT vs MRNA✓SelectedUSD · MRNACPRT vs MRNA performance historyLatest closeAs of-1.91%11/19
Stock and ETF performance explorer

CPRT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-39.3%
MRNA return
+159.5%
Excess return
-198.9%
Maximum drawdown
-58.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.9%+1.3%-3.2%-2.0%
7D-3.6%-13.8%+10.3%-3.0%
30D+10.9%-17.7%+28.5%+11.5%
3M-8.8%+14.3%-23.1%-9.9%
6M-6.8%+336.0%-342.8%-15.8%
YTD-21.2%+575.9%-597.1%-30.4%
1Y-25.4%+724.4%-749.8%-34.8%
All-39.3%+159.5%-198.9%-44.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling